XML 123 R74.htm IDEA: XBRL DOCUMENT v3.19.3
Earnings per Share (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Numerator:        
Net income attributable to Biogen Inc. $ 1,545.9 $ 1,444.4 $ 4,448.8 $ 3,483.9
Weighted-average shares used in calculating:        
Weighted average number of common shares outstanding 184.0 201.4 190.3 206.6
Effect of dilutive securities:        
Dilutive potential common shares 0.2 0.5 0.2 0.4
Shares used in calculating diluted earnings per share 184.2 201.9 190.5 207.0
Stock options and employee stock purchase plan        
Effect of dilutive securities:        
Stock units 0.0 0.0 0.0 0.0
Time-vested restricted stock units        
Effect of dilutive securities:        
Stock units 0.1 0.4 0.1 0.3
Market stock units        
Effect of dilutive securities:        
Stock units 0.1 0.1 0.1 0.1
Performance stock units settled in stock        
Effect of dilutive securities:        
Stock units 0.0 0.0 0.0 0.0